Economic evidence for the prevention and treatment of atopic eczema: A protocol for a systematic review

被引:6
|
作者
Sach T.H. [1 ]
McManus E. [1 ]
Mcmonagle C. [1 ]
Levell N. [2 ]
机构
[1] University of East Anglia, Health Economics Group, Norwich Medical School, Norwich
[2] Norfolk and Norwich University Hospitals NHS Foundation Trust, Dermatology Department, Colney Lane, Norwich
关键词
Cost effectiveness; Costs; Economics; Eczema; Health-related quality of life;
D O I
10.1186/s13643-016-0262-0
中图分类号
学科分类号
摘要
Background: Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases. The proposed research aims to provide a comprehensive systematic assessment of the economic evidence base available to inform economic modelling and decision making on interventions to prevent and treat eczema at any stage of the life course. Whilst the Global Resource of Eczema Trials (GREAT) database collects together the effectiveness evidence for eczema, there is currently no such systematic resource on the economics of eczema. It is important to gain an overview of the current state of the art of economic methods in the field of eczema in order to strengthen the economic evidence base further. Methods/design: The proposed study is a systematic review of the economic evidence surrounding interventions for the prevention and treatment of eczema. Relevant search terms will be used to search MEDLINE, EMBASE, Database of Abstracts of Reviews of Effects, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, National Health Service (NHS) Economic Evaluation Database, Health Technology Assessment, Cumulative Index to Nursing and Allied Health Literature, EconLit, Scopus, Cost-Effectiveness Analysis Registry and Web of Science in order to identify relevant evidence. To be eligible for inclusion studies will be primary empirical studies evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema. Two reviewers will independently assess studies for eligibility and perform data abstraction. Evidence tables will be produced presenting details of study characteristics, costing methods, outcome methods and quality assessment. The methodological quality of studies will be assessed using accepted checklists. Discussion: The systematic review is being undertaken to identify the type of economic evidence available, summarise the results of the available economic evidence and critically appraise the quality of economic evidence currently available to inform future economic modelling and resource allocation decisions about interventions to prevent or treat eczema. We aim to use the review to offer guidance about how to gather economic evidence in studies of eczema and/or what further research is necessary in order to inform this. Systematic review registration: PROSPERO CRD42015024633 © 2016 Sach et al.
引用
收藏
相关论文
共 50 条
  • [21] Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of 'atopic dermatitis'
    Kantor, R.
    Thyssen, J. P.
    Paller, A. S.
    Silverberg, J. I.
    ALLERGY, 2016, 71 (10) : 1480 - 1485
  • [22] The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation
    Garside, R
    Stein, K
    Castelnuovo, E
    Pitt, M
    Ashcroft, D
    Dimmock, P
    Payne, L
    HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (29) : 1 - +
  • [23] Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema) A Systematic Review
    Maleki-Yazdi, Keon Andre
    Heen, Anja Fog
    Zhao, Irene X.
    Guyatt, Gordon H.
    Suzumura, Erica A.
    Makhdami, Nima
    Chen, Lina
    Winders, Tonya
    Wheeler, Kathryn E.
    Wang, Julie
    Spergel, Jonathan
    Silverberg, Jonathan I.
    Ong, Peck Y.
    O'Brien, Monica
    Martin, Stephen A.
    Lio, Peter A.
    Lind, Mary Laura
    LeBovidge, Jennifer
    Kim, Elaine
    Huynh, Joey
    Greenhawt, Matthew
    Frazier, Winfred T.
    Ellison, Kathy
    Capozza, Korey
    De Benedetto, Anna
    Boguniewicz, Mark
    Begolka, Wendy Smith
    Asiniwasis, Rachel Netahe
    Schneider, Lynda C.
    Chu, Derek K.
    JAMA DERMATOLOGY, 2023, 159 (03) : 320 - 330
  • [25] What are the best outcome measurements for atopic eczema? A systematic review
    Schmitt, Jochen
    Langan, Sinead
    Williams, Hywel C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) : 1389 - 1398
  • [26] Probiotics supplement for the prevention of eczema in children Study protocol for a meta-analysis and systematic review
    Yang, Wenhao
    Tu, Renyuan
    Hu, Yanan
    He, Tao
    Zhang, Weijian
    Gu, Li
    Liu, Hanmin
    MEDICINE, 2019, 98 (34)
  • [27] TREATMENT OF ATOPIC ECZEMA
    SNEDDON, I
    BRITISH MEDICAL JOURNAL, 1966, 2 (5527): : 1435 - &
  • [28] TREATMENT OF ATOPIC ECZEMA
    VERBOV, J
    ARCHIVES OF DISEASE IN CHILDHOOD, 1986, 61 (05) : 518 - 521
  • [29] TREATMENT OF ATOPIC ECZEMA
    MARTEN, RH
    PRACTITIONER, 1970, 204 (1219) : 197 - &
  • [30] Probiotics for the treatment of eczema: a systematic review
    Boyle, R. J.
    Bath-Hextall, F. J.
    Leonardi-Bee, J.
    Murrell, D. F.
    Tang, M. L-K
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (08): : 1117 - 1127